person

Raquel M. U.

Country
Spain
Department
Obstetrics and Gynecology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 20 partner sites.

Specializations

Gynecologic Oncology

The investigator concentrates on ovarian cancer, cervical cancer, endometrial cancer, fallopian tube malignancies and peritoneal neoplasms within the scope of gynecologic oncology.

  • Targeted therapy in high‑grade serous ovarian carcinoma
  • Immunotherapy approaches for cervical cancer
  • Adjuvant treatment strategies in endometrial cancer
  • Molecular profiling of fallopian tube malignancies
  • Management of peritoneal carcinomatosis

Research integrates translational biomarkers to refine treatment selection.

Breast Cancer Therapeutics

Key interests include hormone receptor‑positive breast cancer, HER2‑negative breast cancer, triple‑negative breast cancer, HER2‑positive breast cancer and emerging HER2‑low breast cancer subtypes.

  • Endocrine resistance mechanisms in HR+ HER2‑ breast cancer
  • CDK4/6 inhibitor combinations for advanced breast cancer
  • Antibody‑drug conjugates for HER2‑low breast cancer
  • Brain metastasis management in HER2‑positive disease
  • Neoadjuvant immunotherapy in triple‑negative breast cancer

Efforts aim to personalize systemic regimens based on molecular subtypes.

Non‑Small Cell Lung Cancer (NSCLC)

Research focuses on non‑small cell lung cancer subgroups defined by EGFR‑mutated NSCLC, KRAS G12C NSCLC, RET fusion‑positive NSCLC and HER2‑mutated NSCLC.

  • Targeted inhibition of EGFR exon 20 insertion
  • KRAS G12C selective therapy in NSCLC
  • RET inhibitor evaluation in RET fusion‑positive NSCLC
  • Immunotherapy combined with chemotherapy for advanced NSCLC
  • Biomarker‑driven trials in HER2‑mutated NSCLC

Studies emphasize precision medicine for molecularly defined subsets.

Reproductive Medicine & Infertility

Areas of activity encompass infertility, assisted reproductive technologies, prevention of preeclampsia and protocols for elective fertility preservation.

  • Ovarian stimulation protocols for advanced‑age women
  • Luteal phase support optimization in frozen embryo transfer
  • Aspirin prophylaxis in preeclampsia
  • Genetic counseling for infertility
  • Outcomes of elective fertility preservation

Research integrates endocrine and immunologic factors influencing reproductive success.

Menopausal and Genitourinary Health

Focus includes treatment of genitourinary syndrome of menopause using modalities such as local estrogen therapy, autologous platelet‑rich plasma and hyaluronic acid preparations.

  • Comparative efficacy of local estrogen therapy vs autologous platelet‑rich plasma
  • Hyaluronic acid formulations for vaginal atrophy
  • Quality‑of‑life assessment in menopausal women
  • Safety profile of combination PRP‑HA treatments
  • Long‑term outcomes of genitourinary syndrome interventions

Therapeutic aims target symptom relief and tissue regeneration.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.